This archived webinar focuses on new data
developed by Lonza investigating the Low Endotoxin Recovery (LER) phenomenon from
a broad biologics test perspective, and any advances made towards
answering the question as to whether the so-called LER effect is a true concern
for drug product manufacturers.
Learn more and view the archived webinar